Trial Type: Rhabdomyosarcoma

A Phase 3 Study for Newly Diagnosed Rhadomyosarcoma
ARST2032: A Prospective Phase 3 Study of Patients With Newly Diagnosed Very Low-Risk and Low-Risk Fusion Negative Rhabdomyosarcoma
Status: Open
Trial Type: Rhabdomyosarcoma
Contact: Jennifer Welch, MD
jwelch@lifespan.org
A Randomized Phase 3 Trial for High Risk Rhabdomyosarcoma
ARST2031: A Randomized Phase 3 Trial of Vinorelbine, Dactinomycin, and Cyclophosphamide (VINO-AC) Plus Maintenance Chemotherapy with Vinorelbine and Oral Cyclophosphamide (VINO-CPO) vs Vincristine, Dactinomycin and Cyclophosphamide (VAC) plus VINO-CPO Maintenance in Patients with High Risk Rhabdomyosarcoma (HR-RMS)
Status: Open
Trial Type: Rhabdomyosarcoma
Contact: Jennifer Welch, MD
jwelch@lifespan.org

©2024 Brown Cancer Clinical Trials